Flow Traders U.S.’s VanEck Pharmaceutical ETF PPH Stock Holding History

Flow Traders U.S.’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$952K	Sell	8,706 -73,665	-89%	-$7.62M	0.04%	436
2026 Q1	$8.56M	Buy	+82,371	New	+$8.78M	0.27%	69
2025 Q2	–	Sell	-4,768	Closed	-$435K	–	1173
2025 Q1	$435K	Buy	+4,768	New	+$429K	0.02%	633
2023 Q2	–	Sell	-4,169	Closed	-$324K	–	1048
2023 Q1	$324K	Buy	+4,169	New	+$321K	0.01%	592

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Flow Traders U.S.'s PPH Position: Q2 2026 in Review

Flow Traders U.S. reduced its VanEck Pharmaceutical ETF (PPH) stake by 89% in Q2 2026, selling an estimated $7.62M and leaving 8,706 shares worth $952K. The position accounts for 0.04% of the portfolio, ranked #436.

Flow Traders U.S. first reported a position in PPH in Q1 2023 and has held it in 4 quarters since. The position peaked at $8.56M in Q1 2026. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

Flow Traders U.S. held 8,706 shares of VanEck Pharmaceutical ETF worth $952K as of Q2 2026.
Flow Traders U.S. sold 73,665 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $7.62M.
VanEck Pharmaceutical ETF made up 0.04% of Flow Traders U.S.'s portfolio in Q2 2026, its #436 holding.
Flow Traders U.S. first reported a position in VanEck Pharmaceutical ETF in Q1 2023 and has held it in 4 quarters since.
Flow Traders U.S.'s VanEck Pharmaceutical ETF position peaked at $8.56M in Q1 2026.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Flow Traders U.S.'s 13F filing for Q2 2026, filed 14 Aug 2026.